Nov 05, 2011, 06.14 PM IST | Source: Moneycontrol.com

GlaxoSmith Con Sep '11 sales at Rs 744.60 crore

GlaxoSmithKline Consumer Healthcare has reported a sales turnover of Rs 744.60 crore and a net profit of Rs 103.03 crore for the quarter ended Sep '11

GlaxoSmithKline Consumer Healthcare has reported a sales turnover of Rs 744.60 crore and a net profit of Rs 103.03 crore for the quarter ended Sep '11.
For the quarter ended Sep 2010 the sales turnover was Rs 633.02 crore and net profit was Rs 78.57 crore.
Quarterly Results of GlaxoSmithKline Consumer Healthcare-------- in Rs. Cr. --------
Sep '10Jun '11Sep '11
Sales Turnover633.02673.87744.60
Other Income12.9615.4823.11
Total Income645.98689.35767.71
Total Expenses517.51554.84602.07
Operating Profit115.51119.03142.53
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses------
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit128.47134.51165.64
Interest0.730.901.03
PBDT127.74133.61164.61
Depreciation9.9611.3111.65
Depreciation On Revaluation Of Assets------
PBT117.78122.30152.96
Tax39.2139.8449.93
Net Profit78.5782.46103.03
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share18.6819.6124.50
Book Value------
Equity42.0642.0642.06
Reserves------
Face Value10.0010.0010.00
Source : Dion Global Solutions Limited
Set email alert for

ADS BY GOOGLE

Buy & sell politicians on Power Play
- the political stock exchange

Price Update

Arvind Kejriwal

1701.36 -4.19 -0.25%

41084

Bought today

34521

Sold today

0.3%

User holding

video of the day

Chandra says satisfied with TCS' FY14, FY15 to be better

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.